3 transcripts
AUTL
Earnings call transcript
NASDAQ
2024 Q2
8 Aug 24
are working between the different processes, the different systems. And that's a very involved process that we're actually engaged
AUTL
Earnings call transcript
NASDAQ
2024 Q1
17 May 24
cell engaging or CAR T type therapies in the space. So we get a very attractive overall profile. But when we then look at the impact of disease burden
AUTL
Earnings call transcript
NASDAQ
2023 Q2
3 Aug 23
. The design allows us to get a very physiological engagement of the target cells, rapid recognition, rapid kill, and in a rapid disengagement after
- Prev
- 1
- Next